Clinical Scorecard: Enhancing Breast Cancer Screening in National Mammography Facilities: Insights and Challenges of Integrating Additional Ultrasound for Women with Dense Breasts — A Qualitative Analysis

At a Glance

Key Highlights

• Mammography screening reduces breast cancer mortality by approximately 20%.
• Sensitivity of mammography is significantly lower in women with dense breast tissue.
• Ultrasound can improve cancer detection rates by 2–3 cases per 1,000 examinations.
• Current guidelines do not support routine supplemental screening due to potential harms.
• Barriers to integrating US include resource limitations and increased false positives.

Guideline-Based Recommendations

Diagnosis

• Women with dense breast tissue should be informed about their breast density and its implications.

Management

• Consider supplemental ultrasound for women with very dense or heterogeneously dense breast tissue.

Monitoring & Follow-up

• Regular monitoring of screening outcomes and patient experiences is essential.

Risks

• Potential for false positive findings and psychological stress associated with additional testing.

Patient & Prescribing Data

Women aged 50–75 years participating in the national screening program.

Supplemental ultrasound may be beneficial for women with dense breast tissue but is not routinely recommended.

Clinical Best Practices

• Implement automated breast density measurement during mammography.
• Provide educational materials about breast density to screening clients.
• Conduct qualitative assessments to understand patient and provider perspectives on screening.

References

• Cochrane Review on Ultrasound and Mammography
• Guidelines on Breast Cancer Screening